- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
News Release
NIH-supported research suggests sleep patterns to support optimal health can begin in infancy Infants who sleep longer through the night and with fewer interruptions may be less likely to become overweight during their first six months of life, according to a study published in the journal SLEEP . While the research only showed a link – not a cause...
Showing 10 out of 2026 results
|
NHLBI in the Press
Pregnant women with a heart valve condition may benefit from extra cardiovascular monitoring and care, according to a review with thousands of pregnant women with valvular heart disease.
|
NHLBI in the Press
Premature babies’ hearts receive great benefits from breast milk, and those who consumed most do better.
|
NHLBI in the Press
Moving more and sitting less were factors associated with a reduced likelihood of developing obstructive sleep apnea among thousands of health care providers.
|
NHLBI in the Press
Lung ultrasound did not help emergency departments (EDs) manage acute heart failure patients in their initial hours of presenting with symptoms, according to the findings of a randomized pilot trial.
Credit: NIH Image Gallery
|
NHLBI in the Press
A phase 2 study with 59 patients found fostamatinib, a targeted immune therapy used for a rare bleeding disorder, did not result in more adverse outcomes among adults hospitalized for COVID-19 who required assisted breathing support.
|
NHLBI in the Press
The expansion of health insurance has improved, but not quashed, disparities in access to and quality of care for Medicare patients who are from racial and ethnic minorities.
|
NHLBI in the Press
After following more than 123,000 women, ages 50-79, for 15 years, researchers found that those who ate a higher proportion of plant-based foods with healthful fats had a reduced risk for cardiovascular disease, coronary heart disease, and heart failure.
|
News Release
The final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO) demonstrate that COVID-19 convalescent plasma did not prevent disease progression in a high-risk group of outpatients with COVID-19, when administered within the first week of their symptoms. The trial was stopped in February 2021 due to lack of efficacy...